Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsules – RABAVAL DSR Infinia Capsules

RABAVAL DSR Infinia Capsules
Composition:- Rabeprazole 20mg + Domperidone 30mg SR

RABAVAL DSR Infinia Capsules – Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsules combine rabeprazole, a proton pump inhibitor, with Domperidone, a prokinetic agent. Rabeprazole suppresses gastric acid secretion by blocking the H⁺/K⁺ ATPase enzyme, providing relief in GERD and promoting healing of peptic ulcers and acid-related esophageal injury. Domperidone helps control nausea and vomiting while improving gastric emptying by enhancing stomach and intestinal motility.
Marketed by: Wonne International Pvt. Ltd.

Key Points of Enteric Coated Rabeprazole Sodium & Domperidone Sustained Release Capsules – RABAVAL DSR Infinia Capsules

• Dual Mechanism Relief: Rabeprazole effectively controls excess stomach acid, while Domperidone improves gastric movement and alleviates nausea and vomiting.
• Broad Condition Coverage: Offers comprehensive management of GERD, NSAID-associated dyspepsia, gastric and duodenal ulcers, and gastritis.
• Sustained Release Advantage: The SR domperidone layer ensures prolonged prokinetic activity for long-lasting symptom relief throughout the day.

• Gastroenterologist
• General Physician
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.